Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
doi: https://doi.org/10.1101/2020.10.27.20220939
Felice L. Bedford
1University of Arizona, Tucson, AZ, USA
Bastian Greshake Tzovaras
2Université de Paris, Paris, France
Article usage
Posted October 31, 2020.
Re-analysis of genetic risks for Chronic Fatigue Syndrome from 23andMe data finds few remain
Felice L. Bedford, Bastian Greshake Tzovaras
medRxiv 2020.10.27.20220939; doi: https://doi.org/10.1101/2020.10.27.20220939
Subject Area
Subject Areas
- Addiction Medicine (367)
- Allergy and Immunology (688)
- Anesthesia (184)
- Cardiovascular Medicine (2740)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12386)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4252)
- Geriatric Medicine (394)
- Health Economics (699)
- Health Informatics (2749)
- Health Policy (1017)
- Hematology (369)
- HIV/AIDS (878)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4026)
- Nursing (216)
- Nutrition (598)
- Oncology (2122)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (311)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (477)
- Pediatrics (1146)
- Primary Care Research (465)
- Public and Global Health (6644)
- Radiology and Imaging (1444)
- Respiratory Medicine (886)
- Rheumatology (420)
- Sports Medicine (351)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)